Pin It

Υψηλού Επιπέδου Στοματολογική Φροντίδα

Προφίλ

Δρ Ουρανία Νικολάτου-Γαλίτη

Στοματολόγος, Καθηγήτρια Πανεπιστημίου Αθηνών

Η κα Ουρανία Νικολάτου-Γαλίτη είναι απόφοιτος της Οδoντιατρικής Σχολής του Πανεπιστημίου Αθηνών. Απέκτησε το πτυχίο της Παθολογίας Στόματος από Πανεπιστήμιο Temple, Philadelphia, όπου σπούδασε με υποτροφία από τις Η.Π.Α.

Η Καθηγήτρια κα Νικολάτου-Γαλίτη υπηρετεί ως Διευθύντρια της Κλινικής Νοσοκομειακής Οδοντιατρικής και Επιστημονική Υπεύθυνη της Μονάδας Οδοντιατρικής Αντιμετώπισης Ογκολογικού Ασθενούς της Οδοντιατρικής Σχολής του Πανεπιστημίου Αθηνών, www.dent.uoa.gr.

.

Είναι ιδρυτικό μέλος και Πρόεδρος της Ελληνικής Εταιρείας Ογκολογίας Στόματος. Δείτε περισσότερα στο oraloncology.gr.

Είναι επίσης ιδρυτικό Μέλος και έχει διατελέσει Μέλος του Διοικητικού Συμβουλίου της Ελληνικής Εταιρείας Ιατρικής Μυκητολογίας για τα έτη 2002-2005 και 2005-2008

.

Δεξιά: Η κα Νικολάτου-Γαλίτη υπογράφει τη "Διακήρυξη για τον Καρκίνο του Στόματος" σε ειδική Επιστημονική Εκδήλωση, το Μάρτιο του 2011, σε συνεργασία με την Εταιρεία Ογκολόγων Παθολόγων Ελλάδος, την Ελληνική Ακτινοθεραπευτική Εταιρεία και άλλες συνεργαζόμενες Εταιρείες για τον Καρκίνο του Στόματος.

Διεθνής αναγνώριση

Η κα Ουρανία Νικολάτου-Γαλίτη έχει εκλεγεί ως:

  • Chair της Ομάδας Μελέτης των οστικών επιπλοκών και της οστεονέκρωσης www.mascc.org, Bone Study Group
  • Μέλος της Ομάδας των Επιστημονικών Υπευθύνων (Leadership Group) για τη Βλεννογονίτιδα, MASCC/ISOO

  • President του International Society of Oral Oncology

  • Μέλος του Διοικητικού Συμβουλίου του Mediterranean Oncology Forum - MMOF

  • Editor-in-Chief of the Mediterranean Oncology Journal, MOJ

  • Είναι ενεργό μέλος of the Quality of Life Department, European organization for the Research and Treatment of Cancer, EORTC

  • Είναι Επιστημονική Σύμβουλος-Consultant στο IMPAQTT Foundation

  • Δημοσιεύσεις

    Πεδία κλινικού και ερευνητικού ενδιαφέροντος – ερευνητικό έργο

    • Υποστηρικτική Ογκολογία Στόματος
    • Βλεννογονίτιδα του στόματος
    • Οστεονέκρωση των γνάθων
    • Επιπλοκές του στόματος σε ογκολογικές θεραπείες
    • Φροντίδα του στόματος στον καρκίνο
    • Φροντίδα του στόματος σε ασθενείς με μεταμόσχευση αιμοποιητικών κυττάρων (μυελού των οστών)
    • Ποιότητα ζωής στον καρκίνο
    • Οι βλάβες του στόματος σε ειδικούς ασθενείς

    Διεθνείς συνεργασίες

    • International Registry for Osteonecrosis of the Jaw, Principal Investigator for the Site of the Dental School, University of Athens.
    • European Organization for the Research and Treatment of Cancer-EORTC
    • Development of an Οral Ηealth Quality of Life Module (phase I to IV of the EORTC Μodule development.
    • Update of the EORTC QLQ-H&N35, Phase I/IV, Head and Neck Quality of Life Questionnaire Module.
    • Development of the Symptom Based Questionnaire.
    • Development of the Cachexia Module.

    Δημοσιεύσεις στη διεθνή βιβλιογραφία

    1. Development of the EORTC QLQ-CAX24, A Questionnaire for Cancer Patients with Cachexia. Wheelwright SJ, HopkinsonJ, Darlington A.S,  Fitzsimmons D.F, Fayers P,  Balstad T.R,  Bredart A, Hammerlid E,  Kaasa S, Nicolatou-Galitis O. Volume 53, Issue 2, February 2017, Pages 232–242.
    2. International field testing of the psychometric properties of an EORTC quality of life module for oral health: the EORTC QLQ-OH15.Support Care Cancer (2016), Hjermstad MJ, Bergenmar M, Bjordal K, FisherS, Hofmeister D, Montel M, Nicolatou-Galitis O, 24:3915–3924.
    3. Osteonecrosis of the jaw in a patient with acute myeloid leukemia, who received azacitidine. Ourania Nicolatou-Galitis1 , Dimitra Galiti2, Maria Moschogianni3, Sotirios Sachanas3, Beatrice J. Edwards4, Cesar A. Migliorati5, Gerassimos Pangalis6, DOI 20517/2394-4722.2016.06
    4. Periodontal disease preceding osteonecrosis of the jaw (ONJ) in cancer patients receiving antiresorptives alone or combined with targeted therapies: report of 5 cases and literature review. Nicolatou-Galitis O, Razis E, Galiti D, Galitis E, Labropoulos S, Tsimpidakis A, Sgouros J, Karampeazis A, Migliorati C. Oral Surg Oral Med Oral Pathol Oral Radiol 2015; Doi.org/10.1016/j.oooo.2015.08.007.
    5. Measuring quality of life in patients with head and neck cancer: Update of the EORTC QLQ-H&N Module, Phase III. Singer S, Arraras JI, Baumann I, Boehm A, Herlofson BB, Silva JC, Chie WC, Fisher S, Guntinas-Lichius O, Hammerlid E, Irarrazaval ME, Hjermstad MJ, Jensen K, Liyota N, Licitra L, Nicolatou-Galitis O, et al. Head & Neck 2015;37:1358-1367.
    6. Mucormycosis presenting with dental pain and palatal ulcer in a patient with chronic myelomonocytic leukemia. Report of a case and literature review. Nicolatou-Galitis O, Sachanas S, Drogari-Apiranthitou M, Moschogiannis M, Galiti D, Yiakoumis X, Rontogianni D, Yiotakis I, Petrikkos G, Pangalis G. J Medical Microbiology Case Reports, 2015;2. Doi:10.1099/jmmcr.0.000014.
    7. Dental extractions as the major local risk factor of bisphopshonates related jaw osteonecrosis in cancer patients receiving intravenous bsphopshonates therapy. Vardas E, Coward T, Papadopoulou E, Nicolatou-Galitis O. Mediterranean Oncology Journal-MOJ 2014;1:26-33.
    8. Stomatitis, gingivitis and periodontal abscess in a patient with metastatic renal cell carcinoma receiving temsirolimus and bevacizumab: A cumulative toxicity? Nicolatou-Galitis O, Koutsoukos KA, Galitis E, Bamias A, Dimopoulos MA. Mediterranean Oncology Journal-MOJ 2014;1:45-49.
    9. MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy. Lalla RV, Bowen J, Barasch A, Elting L, Epstein J, Keefe DM, McGuire DB, Migliorati C, Nicolatou-Galitis O, Peterson DE, Raber-Durlacher JE, Sonis ST, Elad S. Cancer 2014;120:1453-1461.
    10. International development of an EORTC questionnaire for assessing health-related quality of life in chronic myeloid leukemia patients: the EORTC QLQ-CML24. Efficace F, Baccarani M, Breccia M, Saussele S, Abel G, Caocci G, Guilhot F, Cocks K, Naeem A, Sprangers M, Oerlemans S, Chie W, Castagnetti F, Bombaci F, Sharf G, Cardoni A, Noens L, Pallua S, Salvucci M, Nicolatou-Galitis O, Rosti G, Mandelli F. Qual Life Res 2014;23:825-836.
    11. Osteonecrosis of the jaw in a patient with chronic myelogenous leukemia receiving imatinib. A case report with clinical implications. Nicolatou-Galitis O, Razis E, Galiti D, Vardas E, Tzerbos F, Labropoulos S. Forum of Clinical Oncology 2013;4:29-33.
    12. Systematic review of anti-inflammatory agents for the management of oral mucositis in cancer patients. For the Mucositis Study Group of the Multinational Association of Supportive Care in Cancer/International Society of Oral Oncology. Nicolatou-Galitis O, Sarri T, Bowen J, Di Palma M, Kouloulias VE< Niscola P, Riesenbeck D, Stokman M, Tissing W, Yeoh E, Elad S, Lalla RV. Support Care Cancer 2013;21:3179-3189.
    13. Oral ulcers in patients with advanced breast cancer receiving everolimus: Clinical presentation and management. Nicolatou-Galitis O, Nikolaidi A, Athanassiadis I, Papadopoulou E, Sonis S. Oral Surg Oral Med Oral Pathol Oral Radiol 2013;116:e110-e116.
    14. Performance of the EORTC questionnaire for the assessment of quality of life in head and neck cancer patients EORTC QLQ-H&N35: A methodological review. Singer S, Arraras JI, Chie WC, Fisher SE, Galalae R, Hammerlid E, Nicolatou-Galitis O, Schmaltz C, Verdonck-de Leeuw I, Gamper E, Keszte J, Hofmeister D. Qual Life Research 2013;22:1927-1941.
    15. Systematic review of amifostine for the management of oral mucositis in cancer patients. For the Mucositis Study Group of the Multinational Association of Supportive Care in Cancer/International Society of Oral Oncology. Nicolatou-Galitis O, Sarri T, Bowen J, Di Palma M, Kouloulias VE, Niscola P, Riesenbeck D, Stokman M, Tissing W, Yeoh E, Elad S, Lalla RV. Support Care Cancer 2013;21:357-364.
    16. Quality of life in patients with head and neck cancer receiving targeted or multimodal therapy-Update of the EORTC QLQ-H&N35, Phase I. Singer S, Arraras JI, Bauman I, Boehm A, Chie WC, Galalae R, Langendijk JA, Guntinas-Lichius O, Hammerlid E, Pinto M, Nicolatou-Galitis O, Schmalz C, Sen M, Sherman AC, Spiegel K, Verdonck-de Leew I, Yarom N, Zotti P, Hofmeister D. Head & Neck 2013;35:1331-1338.
    17. Oral ulcers in cancer patients who receive mTOR inhibitors: an emerging oral toxicity. Nicolatou-Galitis O, Bafaloukos D, Manolakis G, Panayiotidis P, Vardas E, Galiti D, Linardou E. Mediterranean Oncology Journal – MOJ 2012;2:45-51.
    18. The EORTC QLQ-OH17: A supplementary module to the EORTC QLQ-C30 for assessment of oral health and quality of life in cancer patients. Hjermstad MJ, Bergenmar M, Fisher SE, Montel S, Nicolatou-Galitis O, et al. European J of Cancer 2012;48:2203-2211.
    19. Gingival bleeding in a patient with cervical cancer receiving bevacizumab. Report of a case. Papadopoulou E, Bafaloukos D, Linardou E, Gatou E, Sarri T, Vardas E, Nicolatou-Galitis O. Mediterranean Oncology Journal MOJ 2012;2:54-56.
    20. Which health-related quality of life aspects are important to patients with chronic myeloid leukemia receiving targeted therapies and to health care professionals? GIMEMA and EORTC Quality of Life Group. Efficace F, Breccia M, Saussele S, Kossak-Roth U, Cardoni A, Caocci G, Chie W, Naeem A, Nicolatou-Galitis O, et al. Ann Hematol 2012;91:1371-1381.
    21. Jaw osteonecrosis associated with medication: Report of two cases addressing unresolved clinical research questions. Nicolatou-Galitis O, Bafaloukos D, Razis E, Papadopoulou E, Linardou E, Grossi I, Vardas E, Migliorati CA. Mediterranean Oncology Journal MOJ 2012;2:45-51.
    22. Gingival bleeding and jaw bone necrosis in patients with metastatic renal cell carcinoma receiving sunitinib: Report of 2 cases with clinical implications. Nicolatou-Galitis O, Migkou M, Psyrri A, Bamias A, Pectasides D, Economopoulos T, Raber-Durlacher JE, Dimitriadis G, Dimopoulos MA. Oral Surg Oral Med Oral Pathol Oral Radiol 2012;113:234-238.
    23. Osteonecrosis of the jaw in oncology patients treated with bisphosphonates: prospective experience of a Dental Oncology referral Center. Nicolatou-Galitis O, Papadopoulou E, Sarri T, Boziari P, Karayianni A, Kyrtsonis MC, Repousis P, Barbounis V, Migliorati CA. Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 2011, 112:195-202.
    24. Oral lichenoid eruption in a patient with chronic myeloid leukemia receiving imatinib. Case report and clinical implications. Nicolatou-Galitis O, Gatou E, Papadopoulou E, Papadaki I, Fisfis M. Mediterranean Oncology Journal MOJ. 2011;1:25-29.
    25. Oral mucositis, pain and xerostomia in 135 head and neck cancer patients receiving radiotherapy with or without chemotherapy. Nicolatou-Galitis O, Kouloulias V, Sotiropoulou-Lontou A, Dardoufas K, Polychronopoulou A, Athanassiadou P, Kolitsi G, Kouvaris J. Open Cancer Journal 2011;4:7-17.
    26. A systematic review of oral fungal infections in patients receiving cancer therapy. Lalla RV, Latortue MC, Hong CH, Ariyawardana A, D’Amato-Palumbo S, Fischer DJ, Martof A, Nicolatou-Galitis O, et al. Support Care Cancer 2010;18:985-992.
    27. Oral mucositis, pain and xerostomia in patients with head and neck cancer who received chemoradiotherapy with or without cetuximab. Nicolatou-Galitis O, Sarri T, Dardoufas K, Kouloulias V, Vakalis X, et al. Open Clinical Cancer Journal 2010;4:6-14.
    28. Granulomatous cheilitis associated with exacerbations of Crohn;s disease: a case report. Triantafillidis JK, Zervou-Valvi F, Merikas E, Peros G, Nicolatou-Galitis O, et al. Medical Case Reports, BioMed Central 2008;2:60.
    29. Oral osteonecrosis associated with the use of ibandronic acid: report of case and clinical implications. Migliorati C, Armonis B, Nicolatou-Galitis O. Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 2008;106:e18-e21.
    30. Osteonecrosis of the jaw in a patient treated with ibandronate. Vomvas D, Vassiliou V, Papavasileiou D, Kalogeropoulou C, Nicolatou-Galitis O, Kardamakis D.J BUON 2008;13:441-443.
    31. Apoptotic and inflammation markers in oral mucositis in head and neck cancer patients receiving radiotherapy: preliminary report. Xanthinaki A, Nicolatou- Galitis O, athanassiadou P, Gonidi M, Kouloulias V, Sotiropoulou-Lontou A, Pissakas G, Kyprianou K, Kouvaris J, Patsouris E. Support Care Cancer 2008;16:1025-1033.
    32. Prolonged survival of an HIV-infected patient with plasmablastic lymphoma of the oral cavity. Panos G, karveli EA, Nikolatou O, Falagas ME. Am J Hematology 2007;82:761-765.
    33. Effect of fluconazole antifungal prophylaxis on oral mucositis in head and neck cancer patients receiving radiotherapy. Nicolatou-Galitis O, Velegraki A, Sotiropoulou-Lontou A, Dardoufas K, Kouloulias V, Kyprianou K, Kolitsi G, Skarleas C, Pissakas G, Papanicolaou VS, Kouvaris J. Support Care Cancer 2006a; 14:44-51.
    34. Herpes simplex virus-1 (HSV-1) infection in radiaton-induced oral mucositis. Nicolatou-Galitis O, Athanassiadou P, Kouloulias V, Sotiropoulou-Lontou A, Dardoufas K, Polychronopoulou A, Gonidi M, Kyprianou K, Kolitsi G, Skarleas C, Pissakas G, Papanicolaou IS, Kouvaris J. Support Care Cancer 2006b;14:753-762.
    35. Silent sinus syndrome, a case presentation. Yiotakis I, Papanikolaou V, Alatzidou Z, Manolopoulos L, Nikolatou-Galiti O, Ferekidis E. Rhinology 2005;43:313-315.
      Effect of PI-HAART on the prevalence of oral lesions in HIV-1 infected patients. A Greek study. Nicolatou-Galitis O, et al. Oral Diseases, 2004, 10:145-150.
    36. Oral candidiasis in head and neck cancer patients receiving radiotherapy with amifostine cytoprotection. Nicolatou-Galitis O, Sotiropoulou-Lontou A, Velegraki A, Pissakas G, Kolitsi G, Kyrpianou K, Kouloulias V, Papanikolaou I, Yiotakis I, Dardoufas K. Oral Oncology 2003;39:397-401.
    37. Oral pseudomembranous candidiasis, herpes simplex virus-1 infection, and oral mucositis in head and neck cancer patients receiving radiotherapy and granulocyte-macrophage colony-stimulating factor (GM-CSF) mouthwash. Nicolatou-Galitis O, Dardoufas K, Markoulatos P, Sotiropoulou-Lontou A, Kyrpianou K, Kolitsi G, Pissakas G, Skarleas C, Kouloulias V, Papanicolaou V, Legakis NJ, Velegraki A. J Oral Pathol Med 2001;30:471-480.
    38. Gingival overgrowth as initial paraneoplastic manifestation of Hodgkin’s lymphoma in a child. Nicolatou-Galitis O, Papadaki T, Moshovi M, Kamma J, Van Vliet-Konstantinidou C, Tzoumakas K, Kattamis A, Tzortzatou-Stathopoulou F. J Periodontology 2001,72:107-112.
    39. The oral manifestations of chronic graft-versus-host disease (cGVHD) in paediatric allogeneic bone marrow tanslant recipients. Nicolatou-Galitis O, Kitra V, Constantinidou C, Peristeri J, Goussetis E, Petropoulos D, Grafakos S. J Oral Pathol Med 2001;30:148-153.
    40. Progress of ossification and epithelization of wounds after simple or surgical extractions of teeth in rats with chronic renal failure: an experimental study. Mylonas AI, Massoulas G, Nicolatou O, et al. Br J Oral Maxillofac Surg 2000; 38:34-43.
    41. Oral hairy leukoplakia in a patient with acute lymphocytic leukemia. Nicolatou O, Nikolatos G, Fisfis M, et al. Oral Dis 1999; 5:76-79.
    42. Oral lesions in children with perinatally acquired human immunodeficiency virus infection. Nicolatou O, et al. J Oral Pathol Med 1999;28:49-53.
    43. Paediatric AIDS-related linear gingival erythema: a form of erythematous candidiasis? Velegraki A, Nicolatou O, et al. J Oral Pathol Med 1999;28:178-182.
    44. A pilot study of the effect of granulocyte-macrophage colony-stimulating factor on oral mucositis in head and neck cancer patients during X-radiation therapy: A preliminary report. Nicolatou O, Sotiropoulou-Lontou A, Skarlatos J, Kyrpianou K, Kolitsi G, Dardoufas K. Int J Radiation Oncology Biol Phys 1998;42:551-556.
    45. Glossodynia: Personality characteristics and psychopathology. Trikkas G, Nikolatou O, et al. Psychother Psychosom 1996;65:163-168.
    46. Verruciform xanthoma of the palate: Case report with electron microscopy. Kakarantza-Angelopoulou E, Nicolatou O, et al. J Oral Maxillofac Surg 1991;49:409-412.
    47. Odontogenic keratocysts: Clinicopathologic study of 87 cases. Kakarantza-Angelopoulou E, Nicolatou O. J Oral Maxillofac Surg 1990;48:593-599.
    48. Oral spindle cell lipoma. Report of a case. Christopoulos P, Nicolatou O, et al. Int J Oral Maxillofac Surg 1989; 18:208-209.
    49. Polymorphous low-grade adenocarcinoma of the palate: Report of a case with electron microscopy. Nicolatou O, et al. J Oral Maxillofac Surg 1988;46:1008-1013.
    50. Correlation of clinical and histological findings of oral tumors. Pierrakou ED, Angelopoulos AP, Nicolatou O. J Oral Med 1986;41:178-183.
    51. Morphologic changes in rat parotid following isoproterenol administration and fractionated X-irradiation. Nicolatou O. J Oral Pathol Med 1981;10:311-321.
    52. Ultrastructural characterization of intermediate cells of mucoepidermoid carcinoma of the parotid. Nicolatou O, et al. Oral Surg Oral Med Oral Pathol 1979; 48:324-336.

     

    Βιβλία

    1. Οι βλάβες του στόματος στον ογκολογικό ασθενή. Νικολάτου-Γαλίτη Ο. Εκδόσεις Μπονισέλ. Αθήνα 2001. Εγχρωμος Ατλαντας.
    2. HIV λοίμωξη / AIDS. Οι βλάβες του στόματος. Νικολάτου-Γαλίτη Ο. Εκδόσεις Omni press. Αθήνα 2006. Εγχρωμος Ατλαντας.
    3. Κεφάλαια σε Βιβλίο-Συνεργασίες με την European Association of Oral Medicine – EAOM
    4. Oral Medicine Handbook. EAOM 2004, on line, www.eastman.ucl.ac.uk/~eaom.
    5. Mucositis (Βλεννογονίτιδα). Nicolatou-Galitis Ο, Spijkervet FKL.
    6. Candidosis (Καντιντίαση). Aguirre JM, Nicolatou-Galitis O.
    7. EAOM Diagnostic and therapeutic protocols: Diagnosis and management of transplantation related oral lesions.
    8. Protocol for diagnosis and management of transplantation related oral lesions. Coordinator: Nicolatou-Galitis O.

    Δείτε περισσότερα για τις στοματολογικές υπηρεσίες ή κλείστε ραντεβού στο στοματολογικό ιατρείο της κυρίας Νικολάτου-Γαλίτη.